Dr. Butts is the oncology pharmacy manager at UK HealthCare and specializes in clinical pharmacy for breast oncology. She received her Bachelor of Science degree in molecular and cellular biology from the University of Illinois at Urbana-Champaign, and her Doctor of Pharmacy degree from the University of Kentucky. She then completed a PGY1 pharmacy practice residency at The Johns Hopkins Hospital and a PGY2 oncology residency at the University of Kentucky Chandler Medical Center. Dr. Butts provides comprehensive pharmaceutical care to patients at the UK Markey Cancer Center, primarily practicing at the Comprehensive Breast Care Center. Additionally, she serves as the PGY2 hematology-oncology pharmacy residency program director and is an assistant adjunct professor at the University of Kentucky College of Pharmacy.
Dr. Chalasani is the director of the hematology-oncology division at the George Washington Cancer Center (GWCC) and co-program lead for the Clinical Translational Oncology Program. After receiving her medical degree from Gandhi Medical College in India, she completed internship, residency and a fellowship in hematology-oncology at the University of Arizona, Tucson. She joined the University of Arizona Cancer Center (UACC) as a faculty member and served as program director for the hematology-oncology fellowship program. Dr. Chalasani is the principal investigator for several clinical trials and was awarded the prestigious NCI Clinical Cancer Investigator Team Leadership Award in 2020. She has received research funding from NIH/NCI, American Cancer Society, Better Than Ever and DOD.
Claudia Franco is a certified physician assistant serving at Inova Schar Cancer Institute in Fairfax, VA providing patient care in the outpatient setting. She strives to provide evidence-based compassionate care to patients with medical oncology and hematology needs. Claudia has a passion for community outreach and providing care to underserved patient populations. She serves as a sub-investigator for several clinical trials in breast cancer at Inova and is a member of the Advanced Practitioner Society for Hematology and Oncology.